Physician profile
Scott R Baker
NPI 1235118209
$1,032.63
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $168 · 2021: $273 · 2022: $104.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $213.59 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $134.78 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.52 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $96.55 | 2019-2021 | |
| Amgen INC. | $64.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.16 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.62 | 2020-2022 | |
| Glaxosmithkline, LLC. | $36.47 | 2019-2022 | |
| Amarin Pharma, INC. | $32.78 | 2019 | |
| Shire North American Group INC | $28.89 | 2019 | |
| Pfizer INC. | $27.44 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $25.75 | 2019 | |
| Lilly USA, LLC | $24.87 | 2020-2021 | |
| Abbvie INC. | $18.22 | 2021 | |
| Astellas Pharma US INC | $16.34 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.23 | 2019 | |
| Kaleo, INC. | $13.56 | 2020 | |
| Ethicon US, LLC | $13.28 | 2019 | |
| Medtronic, INC. | $12.79 | 2021 | |
| Assertio Therapeutics, INC. | $11.89 | 2019 | |
| Allergan, INC. | $11.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.